Jupally meets investors in US

Hyderabad: Commerce minister Jupally Krishna Rao, on Wednesday inaugurated India pavilion at the BIO international convention, Philadelphia, USA, which featured more than 1,700 exhibitors. “India Pavilion” focuses on Government of India’s, Make-in-India programme, to provide major thrust in the biotechnology sector with participation from reputed biotechnology, pharmaceuticals, agri-biotechnology companies, allied industries, government bodies, State governments, Indian institutions and academia.

Jupally also inaugurated the Telangana stall which attracted more investors than any other country at the convention and for announcing the new industrial policy he visited Canada, Korea, Mexico, Russia and other stalls. After that, he participated in INDO US bio-trial trade meeting, which was chaired by Managing Director of Biocon India, Kiran Mazumdar Shaw.

The forum applauded the new industrial policy of Telangana, which was announced recently. The delegates requested the government to liberalise



clinic trial policies and implement Ranjit Roy Chowdary committee report for clinical trials in India. Jupally held talks with Pfizer, Merck, GlaxoSmithKline pharmaceuticals and other leading companies.

Speaking on this occasion, Jupally stated “I feel happy to share that India has been able to successfully position its Biotech industry in the world to capitalise the unfolding global biologic opportunity by attracting talent with advanced technical skill-sets. Telangana has a dominant position in biotechnology, bulk drugs, pharmaceutical sector and life sciences.

”It is the commitment of our policy to fast-track the development of industrial units. All mega projects will be given all permissions within 15 days. Apart from this, there are galore of incentives, subsidies, reimbursements of taxes and tariffs” he added. He invited the global participants for opening manufacturing facilities in Hyderabad, for demonstrating the bright business opportunities with Telangana.